NM_018263.6(ASXL2):c.1228A>T (p.Lys410Ter) AND Shashi-Pena syndrome

Germline classification:: Pathogenic (1 submission)
Last evaluated:: Sep 18, 2018
Review status:: 1 star out of maximum of 4 stars
criteria provided, single submitter

Somatic classification of clinical impact:: None
Review status:: (0/4) 0 stars out of maximum of 4 stars
no assertion criteria provided

Somatic classification of oncogenicity:: None
Review status:: (0/4) 0 stars out of maximum of 4 stars
no assertion criteria provided

Record status:: current
Accession:: RCV000824972.1

Allele description [Variation Report for NM_018263.6(ASXL2):c.1228A>T (p.Lys410Ter)]

NM_018263.6(ASXL2):c.1228A>T (p.Lys410Ter)

Gene:

ASXL2:ASXL transcriptional regulator 2 [Gene - OMIM - HGNC]

Variant type:

single nucleotide variant

Cytogenetic location:

2p23.3

Genomic location:

Preferred name:

NM_018263.6(ASXL2):c.1228A>T (p.Lys410Ter)

HGVS:

NC_000002.12:g.25750328T>A
NG_052995.1:g.133189A>T
NM_001369346.1:c.1054A>T
NM_001369347.1:c.448A>T
NM_018263.6:c.1228A>TMANE SELECT
NP_001356275.1:p.Lys352Ter
NP_001356276.1:p.Lys150Ter
NP_060733.4:p.Lys410Ter
LRG_1421t1:c.1228A>T
LRG_1421:g.133189A>T
LRG_1421p1:p.Lys410Ter
NC_000002.11:g.25973197T>A
NM_018263.4:c.1228A>T

Protein change:

K150*

Links:

dbSNP: rs1574395479

NCBI 1000 Genomes Browser:

rs1574395479

Molecular consequence:

NM_001369346.1:c.1054A>T - nonsense - [Sequence Ontology: SO:0001587]
NM_001369347.1:c.448A>T - nonsense - [Sequence Ontology: SO:0001587]
NM_018263.6:c.1228A>T - nonsense - [Sequence Ontology: SO:0001587]

Condition(s)

Name:: Shashi-Pena syndrome (SHAPNS)
Identifiers:: MONDO: MONDO:0014963; MedGen: C4310672; OMIM: 617190

Recent activity

Clear Turn Off Turn On

Your browsing activity is empty.

Activity recording is turned off.

Turn recording back on

Help

Submission Accession	Submitter	Review Status (Assertion method)	Clinical Significance (Last evaluated)	Origin	Method	Citations
SCV000966147	Equipe Genetique des Anomalies du Developpement, Université de Bourgogne	criteria provided, single submitter (ACMG Guidelines, 2015)	Pathogenic (Sep 18, 2018)	de novo	clinical testing	PubMed (1) [See all records that cite this PMID]

Submission Accession

Submitter

Review Status
(Assertion method)

Clinical Significance
(Last evaluated)

Origin

Method

Citations

SCV000966147

Equipe Genetique des Anomalies du Developpement, Université de Bourgogne

criteria provided, single submitter

(ACMG Guidelines, 2015)

Pathogenic
(Sep 18, 2018)

de novo

clinical testing

PubMed (1)
[See all records that cite this PMID]

Help

Summary from all submissions

Ethnicity	Origin	Affected	Individuals	Families	Chromosomes tested	Number Tested	Family history	Method
not provided	de novo	yes	not provided	not provided	not provided	not provided	not provided	clinical testing

Citations

PubMed

Standards and guidelines for the interpretation of sequence variants: a joint consensus recommendation of the American College of Medical Genetics and Genomics and the Association for Molecular Pathology.

Richards S, Aziz N, Bale S, Bick D, Das S, Gastier-Foster J, Grody WW, Hegde M, Lyon E, Spector E, Voelkerding K, Rehm HL; ACMG Laboratory Quality Assurance Committee..

Genet Med. 2015 May;17(5):405-24. doi: 10.1038/gim.2015.30. Epub 2015 Mar 5.

PubMed [citation]

PMID:: 25741868
PMCID:: PMC4544753

Details of each submission

From Equipe Genetique des Anomalies du Developpement, Université de Bourgogne, SCV000966147.1

#	Ethnicity	Individuals	Chromosomes Tested	Family History	Method	Citations
1	not provided	not provided	not provided	not provided	clinical testing	PubMed (1)

#	Sample				Method		Observation
#	Origin	Affected	Number tested	Tissue	Purpose	Method	Individuals	Allele frequency	Families	Co-occurrences
1	de novo	yes	not provided	not provided	not provided		not provided	not provided	not provided	not provided

Last Updated: Dec 11, 2022

ClinVar

Relating variation to medicine